These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 347289)

  • 1. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
    Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
    N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation for the treatment of immune deficiency states.
    Lenarsky C; Parkman R
    Bone Marrow Transplant; 1990 Dec; 6(6):361-9. PubMed ID: 1965792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of the Wiskott-Aldrich syndrome by a graft of allogeneic bone marrow].
    Fischer A; Durandy A; Bordigoni P; Virelizier JL; Vilmer E; Arnaud-Battandier F; Lagrue A; Olive D; Griscelli C
    Arch Fr Pediatr; 1984 Nov; 41(9):611-6. PubMed ID: 6391414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated donor BMT for Wiskott-Aldrich syndrome.
    Lenarsky C; Weinberg K; Kohn DB; Parkman R
    Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marrow transplantation for nonmalignant disorders.
    Thomas ED
    N Engl J Med; 1978 Apr; 298(17):963-4. PubMed ID: 417247
    [No Abstract]   [Full Text] [Related]  

  • 7. Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with Wiskott-Aldrich syndrome.
    Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schumm M; Handgretinger R
    Bone Marrow Transplant; 2000 Jul; 26(2):235-7. PubMed ID: 10918439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated bone marrow transplantation in a Wiskott-Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor.
    La Nasa G; Pizzati A; Ledda A; Vacca A; Arras M; Contu L
    Haematologica; 1996; 81(2):178-81. PubMed ID: 8641653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation for an infant with neutrophil dysfunction.
    Camitta BM; Quesenberry PJ; Parkman R; Boxer LA; Stossel TP; Cassady JR; Rappeport JM; Nathan DG
    Exp Hematol; 1977 Mar; 5(2):109-16. PubMed ID: 321233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful bone marrow transplantation in sensitized recipients.
    Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
    Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogenic bone marrow transplantation in Wiskott-Aldrich syndrome].
    Maldonado MS; Muñoz A; Otheo de Tejada E; Roldán E; Aymerich L; Brieva JA
    Med Clin (Barc); 1993 Sep; 101(7):258-60. PubMed ID: 7746001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
    Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
    Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with second marrow transplants.
    Wright SE; Thomas ED; Buckner CD; Clift RA; Fefer A; Neiman PE; Storb R
    Exp Hematol; 1976 Jul; 4(4):221-6. PubMed ID: 782896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet function after allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome].
    Megido M; Cesar JM; Maldonado MS; Otheo E; Muñoz A; Navarro JL
    Sangre (Barc); 1993 Jun; 38(3):233-4. PubMed ID: 8211550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation.
    Rappeport JM; Parkman R; Newburger P; Camitta BM; Chusid MJ
    Am J Med; 1980 Apr; 68(4):605-9. PubMed ID: 6989239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.